Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma
Status:
Active, not recruiting
Trial end date:
2027-10-30
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to test the safety, tolerability, and effectiveness of
the combination of three drugs, sorafenib (Nexavar®), valproic acid (Depakote®), and
sildenafil (Viagra®), when used to treat high-grade glioma, a type of brain tumor.